AvePoint (NASDAQ:AVPT) Given New $13.00 Price Target at Citigroup

AvePoint (NASDAQ:AVPT) had its target price decreased by research analysts at Citigroup from $15.00 to $13.00 in a research note issued on Monday,Benzinga reports. The firm presently has a “neutral” rating on the stock. Citigroup’s price objective suggests a potential upside of 22.70% from the stock’s current price.

Other analysts have also recently issued research reports about the company. Zacks Research cut AvePoint from a “strong-buy” rating to a “hold” rating in a report on Friday, January 9th. B. Riley Financial lowered their target price on shares of AvePoint from $25.00 to $22.00 and set a “buy” rating on the stock in a research note on Monday, February 2nd. Weiss Ratings restated a “hold (c-)” rating on shares of AvePoint in a research report on Monday, December 29th. Cantor Fitzgerald decreased their price target on shares of AvePoint from $18.00 to $15.00 and set an “overweight” rating on the stock in a report on Friday. Finally, Jefferies Financial Group dropped their price objective on AvePoint from $20.00 to $16.00 and set a “buy” rating for the company in a research note on Tuesday, February 24th. Eleven investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $17.11.

AvePoint Trading Down 1.7%

Shares of NASDAQ AVPT traded down $0.19 during midday trading on Monday, hitting $10.60. The company’s stock had a trading volume of 1,796,453 shares, compared to its average volume of 2,129,929. The stock has a fifty day moving average price of $12.13 and a 200 day moving average price of $13.65. AvePoint has a one year low of $9.85 and a one year high of $20.25. The firm has a market capitalization of $2.29 billion, a price-to-earnings ratio of 66.27 and a beta of 1.12.

AvePoint (NASDAQ:AVPT) last released its quarterly earnings data on Thursday, February 26th. The company reported $0.07 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.02). AvePoint had a return on equity of 8.19% and a net margin of 8.34%.The business had revenue of $114.69 million during the quarter, compared to the consensus estimate of $110.94 million. On average, equities research analysts predict that AvePoint will post -0.03 earnings per share for the current fiscal year.

Insider Activity at AvePoint

In other AvePoint news, Chairman Xunkai Gong sold 32,002 shares of the company’s stock in a transaction on Monday, January 12th. The shares were sold at an average price of $13.66, for a total value of $437,147.32. Following the completion of the transaction, the chairman directly owned 14,948,666 shares in the company, valued at approximately $204,198,777.56. This represents a 0.21% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 26.19% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On AvePoint

A number of hedge funds and other institutional investors have recently bought and sold shares of AVPT. Morgan Stanley boosted its stake in AvePoint by 372.6% in the 4th quarter. Morgan Stanley now owns 7,871,282 shares of the company’s stock worth $109,332,000 after purchasing an additional 6,205,829 shares in the last quarter. Invesco Ltd. raised its holdings in AvePoint by 218.0% in the second quarter. Invesco Ltd. now owns 5,335,882 shares of the company’s stock worth $103,036,000 after buying an additional 3,657,692 shares during the last quarter. Parsifal Capital Management LP lifted its stake in shares of AvePoint by 61.2% in the third quarter. Parsifal Capital Management LP now owns 8,522,740 shares of the company’s stock worth $127,926,000 after buying an additional 3,235,384 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund lifted its stake in shares of AvePoint by 620.9% in the fourth quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 2,140,572 shares of the company’s stock worth $29,733,000 after buying an additional 1,843,641 shares in the last quarter. Finally, Prudential PLC purchased a new stake in shares of AvePoint during the third quarter valued at approximately $26,824,000. Hedge funds and other institutional investors own 44.49% of the company’s stock.

About AvePoint

AvePoint, Inc (NASDAQ:AVPT) is a leading software provider specializing in data management, governance, and compliance solutions for Microsoft 365 and related cloud platforms. Founded in 2001 and headquartered in Jersey City, New Jersey, the company offers a comprehensive suite of cloud-based and on-premises tools designed to help organizations migrate, manage, and protect their collaboration data. AvePoint’s flagship Cloud Platform delivers backup, governance, reporting, and migration services for SharePoint, Teams, Exchange, OneDrive, and Salesforce environments.

With a customer base spanning thousands of organizations across more than 100 countries, AvePoint serves enterprises, government agencies, and educational institutions seeking to ensure data security, regulatory compliance, and operational resilience.